menu
{ "item_title" : "Multiple Sclerosis Therapeutics", "item_author" : [" Eli Minkoff", "Jeffrey A. Cohen", "Eli Baker "], "item_description" : "Since the publication of the previous edition of this volume, there has been substantial progress in a number of areas of multiple sclerosis (MS) research. Although immunosuppressive treatments continue to be developed and refined, more targeted immunomodulatory therapies are surfacing as we learn more about how the immune system works in health and disease.Multiple Sclerosis Therapeutics, Third Edition provides a comprehensive review of clinical trial methodology and therapeutic modalities in MS. This edition reflects current understanding of the pathophysiology of the disease and includes popular and emerging treatments.Topics include:Biomarkers in MSPharmacogenomicsEmerging therapeutic modalities such as natalizumab, T-cell-based and B-cell-based therapies, cytokine/chemokine-based therapies, statins, and 4-aminopyridineNeuroprotectionThe use of OCT and MRI to guide disease therapyWithin the next several years, we will begin to discover the utility and the limitations of stem cells in the treatment of MS. It is likely that the next edition of this text will include clinical trial data that evaluate early attempts at nervous system regeneration in MS. Until that time occurs, this volume remains an essential resource for neurologists and anyone involved in the treatment of MS.", "item_img_path" : "https://covers3.booksamillion.com/covers/bam/1/84/184/525/1841845256_b.jpg", "price_data" : { "retail_price" : "420.00", "online_price" : "420.00", "our_price" : "420.00", "club_price" : "420.00", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Multiple Sclerosis Therapeutics|Eli Minkoff

Multiple Sclerosis Therapeutics

local_shippingShip to Me
On Order. Usually ships in 2-4 weeks
FREE Shipping for Club Members help

Overview

Since the publication of the previous edition of this volume, there has been substantial progress in a number of areas of multiple sclerosis (MS) research. Although immunosuppressive treatments continue to be developed and refined, more targeted immunomodulatory therapies are surfacing as we learn more about how the immune system works in health and disease.

Multiple Sclerosis Therapeutics, Third Edition provides a comprehensive review of clinical trial methodology and therapeutic modalities in MS. This edition reflects current understanding of the pathophysiology of the disease and includes popular and emerging treatments.

Topics include:

  • Biomarkers in MS
  • Pharmacogenomics
  • Emerging therapeutic modalities such as natalizumab, T-cell-based and B-cell-based therapies, cytokine/chemokine-based therapies, statins, and 4-aminopyridine
  • Neuroprotection
  • The use of OCT and MRI to guide disease therapy

Within the next several years, we will begin to discover the utility and the limitations of stem cells in the treatment of MS. It is likely that the next edition of this text will include clinical trial data that evaluate early attempts at nervous system regeneration in MS. Until that time occurs, this volume remains an essential resource for neurologists and anyone involved in the treatment of MS.

This item is Non-Returnable

Details

  • ISBN-13: 9781841845258
  • ISBN-10: 1841845256
  • Publisher: CRC Press
  • Publish Date: October 2006
  • Dimensions: 9.91 x 7.79 x 2.14 inches
  • Shipping Weight: 5.9 pounds
  • Page Count: 928

Related Categories

You May Also Like...

    1

BAM Customer Reviews